Cover Image
市場調查報告書

EpiCast Report:乾癬的流行病學預測

EpiCast Report: Psoriasis - Epidemiology Forecast to 2024

出版商 GlobalData 商品編碼 267091
出版日期 內容資訊 英文 39 Pages
訂單完成後即時交付
價格
Back to Top
EpiCast Report:乾癬的流行病學預測 EpiCast Report: Psoriasis - Epidemiology Forecast to 2024
出版日期: 2015年10月14日 內容資訊: 英文 39 Pages
簡介

本報告提供全球乾癬調查分析、危險因素概要、主要7個市場(美國、法國、德國、義大利、西班牙、英國、日本)和新興2個市場(印度、中國)的資料、今後10年的流行病學預測等,為您概述為以下內容。

第1章 目錄

第2章 簡介

第3章 流行病學

  • 疾病的背景
  • 危險因素和共生病症
  • 全球趨勢
    • 盛行率
  • 預測手法
    • 利用之資訊來源
    • 預測的前提條件與手法
    • 未利用之資訊來源
  • 流行病學預測
    • 乾癬的發病數量
    • 各年齡
    • 性別
    • 年齡標準化的盛行率
    • 重症度別發病數量
  • 議論
    • 流行病學的預測考察
    • 分析的限制
    • 分析的優勢

第4章 附錄

圖表

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GDHCER098-15

Psoriasis is a chronic, immune-mediated inflammatory skin disease. Psoriasis ranges in severity from a few scattered, sharply demarcated, scaly, red, coin-sized skin lesions or scaly plaques to involvement of almost the entire body surface. Psoriasis is more prevalent in colder areas, and less prevalent in the tropics and warmer regions of the world. Globally, the one-year prevalence of psoriasis varies with the differences in prevalence of psoriasis attributed to variations in environmental factors, genetic factors, and differences in the case definition used to diagnose psoriasis in epidemiology studies.

GlobalData epidemiologists forecast an increase in the one-year diagnosed prevalent cases of psoriasis in the 8MM, from 43,747,201 cases in 2014 to 50,455,013 cases in 2024, with an Annual Growth Rate (AGR) of 1.53% during the forecast period. In 2024, India will have the highest number of one-year diagnosed prevalent cases of psoriasis in the 8MM, with 32,853,676 cases, whereas Japan will have the lowest number of one-year diagnosed prevalent cases of psoriasis, with 482,431 cases in 2024.

This report provides an overview of the risk factors, comorbidities, and the global and historical trends for psoriasis in the eight major markets (8MM) (US, France, Germany, Italy, Spain, UK, Japan, and India). The report also provides a 10-year epidemiological forecast of the one-year diagnosed prevalent cases of psoriasis segmented by sex, age (at 10-year intervals, starting at age zero years and ending at ages =80 years), and severity (mild, moderate, and severe) in the 8MM.

Scope

  • The Psoriasis EpiCast Report provides an overview of the risk factors, comorbidities, and the global and historical trends for psoriasis in the eight major markets (8MM) (US, France, Germany, Italy, Spain, UK, Japan, and India). The report also provides a 10-year epidemiological forecast of the one-year diagnosed prevalent cases of psoriasis segmented by sex, age (at 10-year intervals, starting at age zero years and ending at ages =80 years), and severity (mild, moderate, and severe) in the 8MM. GlobalData epidemiologists forecast the one-year diagnosed prevalent cases of psoriasis in the 8MM from 2014-2024 using data obtained from peer-reviewed journals that provide one-year diagnosed prevalence of psoriasis in the respective markets. Psoriasis one-year diagnosed prevalent cases are further segmented by severity.
  • The psoriasis epidemiology report is written and developed by Masters- and PhD-level epidemiologists.
  • The EpiCast Report is in-depth, high quality, transparent and market-driven, providing expert analysis of disease trends in the 8MM.

Reasons to buy

The Psoriasis EpiCast series will allow you to -

  • Develop business strategies by understanding the trends shaping and driving the global psoriasis market.
  • Quantify patient populations in the global psoriasis market to improve product design, pricing, and launch plans.
  • Organize sales and marketing efforts by identifying the age groups and sex that present the best opportunities for psoriasis therapeutics in each of the markets covered.

Table of Contents

1. Table of Contents

  • 1.1. List of Tables
  • 1.2. List of Figures

2. Introduction

  • 2.1. Catalyst
  • 2.2. Related Reports
  • 2.3. Upcoming Related Reports

3. Epidemiology

  • 3.1. Disease Background
  • 3.2. Risk Factors and Comorbidities
  • 3.3. Global Trends
    • 3.3.1. Prevalence
  • 3.4. Forecast Methodology
    • 3.4.1. Sources Used for One-Year Diagnosed Prevalence of Psoriasis
    • 3.4.2. Sources Not Used
    • 3.4.3. Forecast Assumptions and Methods, One-Year Diagnosed Prevalent Cases of Psoriasis
  • 3.5. Epidemiological Forecast for Psoriasis (2014-2024)
    • 3.5.1. One-Year Diagnosed Prevalent Cases of Psoriasis
    • 3.5.2. Age-Specific One-Year Diagnosed Prevalent Cases of Psoriasis
    • 3.5.3. Sex-Specific One-Year Diagnosed Prevalent Cases of Psoriasis
    • 3.5.4. Age-Standardized One-Year Diagnosed Prevalent Cases of Psoriasis
    • 3.5.5. One-Year Diagnosed Prevalent Cases of Psoriasis by Severity
  • 3.6. Discussion
    • 3.6.1. Epidemiological Forecast Insight
    • 3.6.2. Limitations of the Analysis
    • 3.6.3. Strengths of the Analysis

4. Appendix

  • 4.1. Bibliography
  • 4.2. About the Authors
    • 4.2.1. Epidemiologists
    • 4.2.2. Reviewers
    • 4.2.3. Global Director of Therapy Analysis and Epidemiology
    • 4.2.4. Global Head of Healthcare
  • 4.3. About GlobalData
  • 4.4. About EpiCast
  • 4.5. Disclaimer

List of Tables

  • Table 1: Risk Factors and Comorbidities for Psoriasis
  • Table 2: 8MM, Global Trends for the Diagnosed Prevalence of Psoriasis
  • Table 3: 8MM, Sources of Epidemiological Data Used for the Forecast for Psoriasis One-Year Diagnosed Prevalent Cases
  • Table 4: 8MM, Sources of Epidemiological Data Used for the Segmentation of One-Year Diagnosed Prevalent Cases of Psoriasis by Severity
  • Table 5: 8MM, One-Year Diagnosed Prevalent Cases of Psoriasis, Both Sexes, All Ages, N, 2014-2024
  • Table 6: 8MM, Age-Specific One-Year Diagnosed Prevalent Cases of Psoriasis, Both Sexes, N (Row %), 2014
  • Table 7: 8MM, Sex-Specific One-Year Diagnosed Prevalent Cases of Psoriasis, All Ages, N (Row %), 2014

List of Figures

  • Figure 1: 8MM, One-Year Diagnosed Prevalent Cases of Psoriasis, Both Sexes, All Ages, N, 2014-2024
  • Figure 2: 8MM, Age-Specific One-Year Diagnosed Prevalent Cases of Psoriasis, Both Sexes, N, 2014
  • Figure 3: 8MM, Sex-Specific One-Year Diagnosed Prevalent Cases of Psoriasis, All Ages, N, 2014
  • Figure 4: 8MM, Age-Standardized One-Year Diagnosed Prevalent Cases of Psoriasis (%), All Ages, by Sex, 2014
  • Figure 5: 8MM, Severity Profile of One-Year Diagnosed Prevalent Cases of Psoriasis, All Ages, Both Sexes, N, 2014
Back to Top